Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-260467
Filing Date
2018-08-28
Accepted
2018-08-28 14:32:35
Documents
7
Period of Report
2018-10-04
Effectiveness Date
2018-08-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d607019ddef14a.htm DEF 14A 656658
2 GRAPHIC g607019g10r12.jpg GRAPHIC 24294
3 GRAPHIC g607019g68d40.jpg GRAPHIC 7348
4 GRAPHIC g607019g82l95.jpg GRAPHIC 13033
5 GRAPHIC g607019page054.jpg GRAPHIC 208388
6 GRAPHIC g607019page055.jpg GRAPHIC 244040
7 GRAPHIC g607019page056.jpg GRAPHIC 277008
  Complete submission text file 0001193125-18-260467.txt   1724383
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 000-17988 | Film No.: 181041307
SIC: 2835 In Vitro & In Vivo Diagnostic Substances